Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009
- PMID: 21801776
- PMCID: PMC5832019
- DOI: 10.1016/j.vaccine.2011.07.044
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009
Abstract
Background: In 2004 the Clinical Consult Case Review (CCCR) working group was formed within the CDC-funded Clinical Immunization Safety Assessment (CISA) Network to review individual cases of adverse events following immunizations (AEFI).
Methods: Cases were referred by practitioners, health departments, or CDC employees. Vaccine Adverse Event Reporting System (VAERS) searches and literature reviews for similar cases were performed prior to review. After CCCR discussion, AEFI were assessed for a causal relationship with vaccination and recommendations regarding future immunizations were relayed back to the referring physicians. In 2010, surveys were sent to referring physicians to determine the utility and effectiveness of the CCCR service.
Results: CISA investigators reviewed 76 cases during 68 conference calls between April 2004 and December 2009. Almost half of the cases (35/76) were neurological in nature. Similar AEFI for the specific vaccines received were discovered for 63 cases through VAERS searches and for 38 cases through PubMed searches. Causality assessment using the modified WHO criteria resulted in classifying 3 cases as definitely related to vaccine administration, 12 as probably related, 16 as possibly related, 18 as unlikely related, 10 as unrelated, and 17 had insufficient information to assign causality. The physician satisfaction survey was returned by 30 (57.7%) of those surveyed and a majority of respondents (93.3%) felt that the CCCR service was useful.
Conclusions: The CCCR provides advice about AEFI to practitioners, assigns potential causality, and contributes to an improved understanding of adverse health events following immunizations.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Subcutaneous nodules: an important adverse event following immunization.Expert Rev Vaccines. 2019 Apr;18(4):405-410. doi: 10.1080/14760584.2019.1586540. Epub 2019 Mar 11. Expert Rev Vaccines. 2019. PMID: 30808246 Review.
-
Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness.Vaccine. 2018 Jan 4;36(2):299-305. doi: 10.1016/j.vaccine.2017.11.017. Epub 2017 Nov 29. Vaccine. 2018. PMID: 29198916 Free PMC article. Review.
-
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Vaccine. 2012 Nov 26;30(50):7253-9. doi: 10.1016/j.vaccine.2012.09.074. Epub 2012 Oct 9. Vaccine. 2012. PMID: 23063829
-
Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.Vaccine. 2011 Oct 26;29(46):8302-8. doi: 10.1016/j.vaccine.2011.08.093. Epub 2011 Sep 3. Vaccine. 2011. PMID: 21893148 Free PMC article.
-
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502239
Cited by
-
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.Vaccine. 2023 Jun 7;41(25):3790-3795. doi: 10.1016/j.vaccine.2023.04.055. Epub 2023 May 15. Vaccine. 2023. PMID: 37198019 Free PMC article. Review.
-
Multiple cranial nerve palsies with small angle exotropia following COVID-19 mRNA vaccination in an adolescent: A case report.World J Clin Cases. 2022 Nov 26;10(33):12289-12294. doi: 10.12998/wjcc.v10.i33.12289. World J Clin Cases. 2022. PMID: 36483824 Free PMC article.
-
Vaccine-Associated Anaphylaxis.Curr Treat Options Allergy. 2019 Sep;6(3):297-308. doi: 10.1007/s40521-019-00215-0. Epub 2019 Jul 16. Curr Treat Options Allergy. 2019. PMID: 31815089 Free PMC article.
-
Immune-mediated adverse reactions to vaccines.Br J Clin Pharmacol. 2019 Dec;85(12):2694-2706. doi: 10.1111/bcp.14112. Epub 2019 Nov 5. Br J Clin Pharmacol. 2019. PMID: 31472022 Free PMC article. Review.
-
Vaccine safety: An evolving evidence-based science.Br J Clin Pharmacol. 2019 Dec;85(12):2649-2651. doi: 10.1111/bcp.14080. Epub 2019 Aug 19. Br J Clin Pharmacol. 2019. PMID: 31373717 Free PMC article. No abstract available.
References
-
- Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 2004 Oct 13;292(14):1696–701. - PubMed
-
- Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007 Nov 14;298(18):2155–63. - PubMed
-
- Cisse MF, Breugelmans JG, Ba M, Diop MB, Faye PC, Mhlanga B, et al. The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal. Pediatr Infect Dis J. 2010 Jun;29(6):499–503. - PubMed
-
- Schoendorf KC, Adams WG, Kiely JL, Wenger JD. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994 Apr;93(4):663–8. - PubMed
-
- Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 May 19;55(RR-7):1–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous